NCT06026774View on ClinicalTrials.gov

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 8, 2023

Primary Completion Date

August 31, 2027

Study Completion Date

December 31, 2027

Conditions
Digestive System Neoplasms
Interventions
BIOLOGICAL

iNeo-Vac-R01 in combination with standard adjuvant therapy

Personalized mRNA vaccine encoding neoantigen, IH injection

Trial Locations (1)

310000

RECRUITING

Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, Hangzhou

All Listed Sponsors
collaborator

Hangzhou Neoantigen Therapeutics Co., Ltd.

INDUSTRY

lead

Sir Run Run Shaw Hospital

OTHER